Johnson & Johnson has disclosed an FTC investigation into its Remicade contracting. (Flickr user nathanmac87) () Johnson & Johnson's big-selling Remicade has held most of its ground against biosimilar ...
Merck has launched Renflexis, a Remicade biosimilar, in the U.S. under a partnership with Samsung. () After the first biosimilar of Johnson & Johnson’s big-selling immunology drug Remicade hit the ...
The global remicade biosimilar market is projected to expand significantly between 2025 and 2035, with a market size growing from USD 2.32 billion in 2025 to USD 4.01 billion in 2035, at a robust ...
Oct 17 (Reuters) - Pfizer Inc said on Monday it will begin shipping its biosimilar version of Johnson & Johnson's blockbuster rheumatoid arthritis drug Remicade in late November at a 15 percent ...
Pfizer Inc. filed suit against Johnson & Johnson, alleging J&J thwarted competition to its arthritis therapy Remicade, in a case that could shatter arrangements pharmaceutical companies make with ...
Pfizer is suing Johnson & Johnson, alleging that it induced US health insurers to help it block biosimilar competition to its blockbuster Remicade. Pfizer's Inflectra was the first monoclonal antibody ...
(Reuters) - U.S. Food and Drug Administration staff members on Friday said Celltrion Inc's biosimilar form of Johnson & Johnson's Remicade arthritis drug appeared "highly similar" to the widely used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results